Halozyme Therapeutics | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 650.22M 51.62M 2024-09
Amgen USD 26.93B 2.1B 2025-03
Baxter International USD 8.85B 11M 2024-12
Cytokinetics USD 956.05M 151.89M 2025-03
DBV Technologies USD 68.76M 21.2M 2024-09
Eli Lilly USD 41.26B 8.52B 2025-03
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Indivior 883M 44M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
MannKind USD 268.31M 59.36M 2024-12
Pfizer USD 45.86B 4.5B 2025-03
United Therapeutics USD 3.94B 65.9M 2025-03



Halozyme Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.